CRML Completes Tanbreez Consolidation with Major Dilution; Strategic Review and Delayed DFS Shift Risk Profile

What happened

Critical Metals Corp. announced completion of the European Lithium merger and now holds 100% of the Tanbreez rare earth project, consolidating control but also absorbing the full project risk. The company reports $264.5 million in cash and 194.2 million shares outstanding, indicating substantial equity dilution compared to the ~93 million shares outstanding at the start of 2026, as financing was used to fund the acquisition and operations. A strategic review is underway, which may lead to asset sales, partnerships, or a sale of the company, though details are sparse and could reflect balance-sheet stress or value-maximization intent. The definitive feasibility study for Tanbreez is now targeted for Q4 2027, a significant delay from previous timelines that anticipated BFS/EIA submission in late 2025 and early Greenland feedback by 2026. While the cash balance reduces near-term liquidity concerns, the massive share count increase and slower project timeline suggest that prior dilution fears have materialized, and the risk-reward has shifted.

Implication

The doubling of share count at a likely lower share price has destroyed per-share value unless the Tanbreez acquisition was acquired at an attractive per-share cost; the $264.5 million cash provides runway but likely was raised at depressed prices, further harming existing holders. The strategic review introduces uncertainty: a sale could crystallize value if a premium is offered, but if it signals inability to fund the project independently, a fire sale or continued dilution is more likely. The DFS slip to Q4 2027 pushes any potential production decision and financing commitments further out, reducing the present value of Tanbreez and testing investor patience. With 100% ownership, CRML now bears the full capital intensity and permitting risk of Tanbreez in Greenland, which the market had previously partially mitigated through the joint venture structure. Given the unchanged fundamental challenges and the materialized dilution, the thesis that CRML was overvalued at $13.17 is reinforced, and any rebound should be viewed as an opportunity to reduce exposure unless the strategic review produces a credible value-unlocking transaction.

Thesis delta

The previous STRONG SELL thesis highlighted high probability of equity dilution and schedule slippage; both have now occurred with shares outstanding doubling and DFS delayed to Q4 2027. However, the $264.5 million cash position temporarily reduces the immediate liquidity risk that underpinned the bear case, but it came at the cost of severe dilution, so the per-share economics may be worse. The 100% ownership of Tanbreez simplifies the structure but increases downside exposure, and the strategic review adds a new catalyst that could cut both ways; overall the risk-reward remains unfavorable given the lower per-share asset value after dilution.